Top

Reactions Weekly

Published in:

01-03-2012 | Case report

Cisplatin/gimeracil/oteracil/tegafur

Loss of appetite and vomiting: case report

Published in: Reactions Weekly | Issue 1/2012

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:

death
life-threatening
hospitalisation
disability
congenital anomaly
requires intervention to prevent permanent impairment or damage

…

Uji K, Tamura S, Takeno A, Miki H, Kanemura T, Yanai A, Kobayashi M, Yoshioka Y, Teramoto A, Nakahira S, Suzuki R, Nakata K, Egawa C, Okamura S, Sugimoto K, Takatsuka Y.A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective. Gan to Kagaku Ryoho 38: 1691-1694, No. 10, Oct 2011 - Japan

Title: Cisplatin/gimeracil/oteracil/tegafur
Loss of appetite and vomiting: case report
Publication date: 01-03-2012
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201213920-00049

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cisplatin/gimeracil/oteracil/tegafur

Loss of appetite and vomiting: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Gefitinib

Lamivudine/nevirapine/stavudine

Pregabalin

Triamcinolone

Busulfan

Trihexyphenidyl